Here, we investigated all the previous reports and found that the SPTB gene mutation-associated HS accounts for 20%–25% of all HS cases in Europe and the United States, while it showed a potentially higher rate in China (Perrotta et al., 2008; Wang et al., 2018; Hassoun et al., 1997). Here, SPTB is linked to histiocytic sarcoma.